Literature DB >> 16479979

[Acute pancreatitis during the treatment of relapsed acute promyelocytic leukemia with As2O3].

Takeshi Yamano1, Taiji Yokote, Toshikazu Akioka, Satoshi Hara, Tomoko Oka, Motomu Tsuji, Toshiaki Hanafusa.   

Abstract

A 77-year-old man suffered from acute pancreatitis during the treatment of relapsed acute promyelocytic leukemia with As2O3. He presented with epigastralgia on day 25 during the treatment with As2O3. Pancreatic enzyme levels were elevated and the computed tomography scan of the abdomen showed swelling of the pancreas. As acute pancreatitis due to As2O3 was suspected, As2O3 was discontinued. Intravenous gabexate mesilate was administered, and the pancreatitis improved. Acute pancreatitis should be considered as a possible complication during treatment with As2O3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479979

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  4 in total

1.  Arsenic-induced pancreatitis.

Authors:  Sean Connelly; Krysia Zancosky; Katie Farah
Journal:  Case Rep Gastrointest Med       Date:  2011-10-05

2.  Pancreatitis in Acute Promyelocytic Leukemia: Drug-induced or Differentiation Syndrome?

Authors:  Dibyendu De; Uttam Kumar Nath; Prantar Chakrabarti
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep

Review 3.  Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo.

Authors:  Chinthalapally V Rao; Sanya Pal; Altaf Mohammed; Mudassir Farooqui; Mark P Doescher; Adam S Asch; Hiroshi Y Yamada
Journal:  Oncotarget       Date:  2017-05-10

4.  Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report.

Authors:  Yan Jiang; Linhua Ji
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.